Core Scientific, Inc.
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.8% | 15.3% | 12.4% | 0.9% | 6.0% | 14.5% | -56.6% | 43.2% | 162.5% | 191.9% | 216.8% | -11.5% | 117.1% | |
| 21.7% | 21.8% | 16.6% | 22.3% | 31.2% | 30.7% | 28.2% | 27.3% | 23.6% | 7.3% | 17.2% | 9.4% | 13.7% | |
| 13.2% | 12.3% | -0.6% | 6.0% | 21.5% | 25.2% | 20.4% | 30.7% | 36.9% | 35.0% | 15.4% | 11.1% | 21.3% | |
| 79.7% | 187.0% | 74.4% | 56.0% | 345.5% | 25.6% | 20.9% | 127.4% | 269.8% | 237.0% | 54.0% | -99.6% | 69.6% | |
| 2.4% | 8.2% | 17.8% | 2.2% | 32.6% | 30.3% | 105.6% | 154.2% | 313.9% | 344.5% | 337.7% | 344.1% | 337.0% | |
| -2.5% | 1.7% | -17.8% | -2.3% | -32.8% | -30.3% | -111.9% | -152.1% | -313.6% | -342.7% | -335.5% | -484.9% | -388.5% | |
| 0.0% | 0.0% | -1.9% | 2.4% | – | – | – | – | – | – | – | -8.3% | – | |
| – | – | – | – | 192.1% | 631.1% | -5.6% | -6.7% | -0.7% | 0.0% | 862.4% | 1,998.4% | 970.8% | |
| -13.6% | -12.9% | 30.3% | -10.8% | 191.1% | 630.2% | -5.3% | -40.4% | -6.6% | -27.3% | 842.9% | 1,352.4% | 718.8% | |
| -11.4% | 4.1% | 24.9% | -12.2% | 164.3% | 614.4% | -173.9% | -149.3% | -157.7% | -178.1% | 654.3% | 855.9% | 429.1% | |
| 2.4% | 7.1% | -5.4% | -1.4% | -26.6% | -15.8% | -162.3% | -111.0% | -151.5% | -152.6% | -120.9% | -355.6% | -219.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.